Enzalutamide
恩扎卢胺
Report date: 2026/03/18 10:10:34
NME
Base Information
Drug NameEnzalutamide
Drug Alias Name +[12]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[19]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2012/08/31
Country/Territory +[46]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUniversity Of California At Los AngelesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A
Develop Information
Active CompaniesMedivation LlcAstellas Pharma Us IncUniversity of Sydney +[14]
Inactive CompaniesDana-Farber Cancer InstituteAlessa Therapeutics IncThe Netherlands Cancer Institute +[12]
Active Indications +[8]
Inactive Indications +[11]